Commercializing a breakthrough advance in inflammation science. MORE
Antibe Therapeutics is a publicly traded biotechnology company exploiting groundbreaking advances in inflammation science.
Antibe Therapeutics Expands Executive Team in Preparation for Large Market Partnering
Antibe Therapeutics Provides Corporate Update and Reports Q2 2020 Interim Financial and Operating Results
Antibe Therapeutics Provides Update on Phase 2B Dose-Ranging, Efficacy Study for ATB-346